{"id":3199,"date":"2025-02-11T17:41:57","date_gmt":"2025-02-12T01:41:57","guid":{"rendered":"https:\/\/capca.ca\/document\/immune-effector-cell-therapy-for-adult-patients-in-canada-consensus-statement-september-2024\/"},"modified":"2025-05-06T10:43:25","modified_gmt":"2025-05-06T17:43:25","slug":"la-therapie-par-cellules-effectrices-immunitaires-chez-les-patients-adultes-au-canada-declaration-de-consensus","status":"publish","type":"document","link":"https:\/\/capca.ca\/fr\/document\/la-therapie-par-cellules-effectrices-immunitaires-chez-les-patients-adultes-au-canada-declaration-de-consensus\/","title":{"rendered":"La th\u00e9rapie par cellules effectrices immunitaires chez les patients adultes au Canada\u00a0: D\u00e9claration de consensus"},"content":{"rendered":"\n<div>\n<div class=\"capca-inner-container gb-element-c7575eeb\">\n<div class=\"gb-element-4781ee1e\">\n<p class=\"wp-block-paragraph\">L\u2019objectif de ce document est de fournir des conseils sur l\u2019application des indications des avis de conformit\u00e9 (AC) de Sant\u00e9 Canada, qui sont financ\u00e9es par l\u2019\u00c9tat, et de donner des pr\u00e9cisions sur les crit\u00e8res qui n\u2019ont pas \u00e9t\u00e9 inclus dans les crit\u00e8res de remboursement recommand\u00e9s par l\u2019ACMTS pour les patients adultes auxquels on envisage d\u2019administrer une th\u00e9rapie CAR-T. Ce document vise \u00e0 soutenir l\u2019utilisation normalis\u00e9e de cette th\u00e9rapie au Canada.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cela aidera les cliniciens, les d\u00e9cideurs et les payeurs responsables des d\u00e9cisions de traitement et de financement. Un consensus sur l\u2019utilisation de la th\u00e9rapie CAR-T permettra \u00e9galement d\u2019harmoniser l\u2019acc\u00e8s entre les provinces.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/capca.ca\/wp-content\/uploads\/2025\/04\/Adult-IEC-Consensus-Statement-20240917-Final.pdf\">Voir les ressources<\/a>  (disponible en anglais uniquement)<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Ce document a pour objectif d\u2019uniformiser les crit\u00e8res d\u2019admissibilit\u00e9 \u00e0 la th\u00e9rapie CAR-T au Canada.<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_crdt_document":"","_piecal_is_recurring":false,"_piecal_recurring_interval":1,"_piecal_recurring_frequency":"","_piecal_recurring_exact_position":false,"_piecal_recurring_end":"","_piecal_color":"","_piecal_text_color":"","_piecal_global_color_master":false,"_piecal_rsets":"[]","_piecal_is_event":false,"_piecal_start_date":"","_piecal_end_date":"","_piecal_is_allday":false,"inline_featured_image":false},"document-cancer-site":[187],"document-capca-initiative":[199],"document-resource-type":[175],"document-topic":[185],"document-treatment-modality":[195],"featured-item":[145],"class_list":["post-3199","document","type-document","status-publish","hentry","document-cancer-site-hematologie-cancers-du-sang","document-capca-initiative-acces-et-qualite-de-la-therapie-par-cellules-effectrices-immunitaires","document-resource-type-document-dorientation-consensuel","document-topic-acces-aux-soins","document-treatment-modality-therapie-par-cellules-effectrices-immunitaires","featured-item-show-on-home-page"],"acf":[],"_links":{"self":[{"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document\/3199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document"}],"about":[{"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/types\/document"}],"wp:attachment":[{"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/media?parent=3199"}],"wp:term":[{"taxonomy":"document-cancer-site","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-cancer-site?post=3199"},{"taxonomy":"document-capca-initiative","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-capca-initiative?post=3199"},{"taxonomy":"document-resource-type","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-resource-type?post=3199"},{"taxonomy":"document-topic","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-topic?post=3199"},{"taxonomy":"document-treatment-modality","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/document-treatment-modality?post=3199"},{"taxonomy":"featured-item","embeddable":true,"href":"https:\/\/capca.ca\/fr\/wp-json\/wp\/v2\/featured-item?post=3199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}